Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.
about
UK guidelines for the management of bone sarcomasTwenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to CollaborationSequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic LandscapesUnderstanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionChildren's Oncology Group's 2013 blueprint for research: bone tumorsManagement of Ewing sarcoma family of tumors: Current scenario and unmet needDiagnosis and treatment of Ewing sarcoma of the bone: a review articleClinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology GroupMedicines for cancers in children: The WHO model for selection of essential medicines.Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies.Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas.Vaginal Ewing Sarcoma: An Uncommon Clinical Entity in Pediatric Patients.Patient-Reported Functional and Quality of Life Outcomes in a Large Cohort of Long-Term Survivors of Ewing SarcomaNew strategies in ewing sarcoma: lost in translation?What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1Treatment pathway of bone sarcoma in children, adolescents, and young adultsCollaborative Pediatric Bone Tumor Program to Improve Access to Specialized Care: An Initiative by the Lebanese Children's Oncology Group.Outcome for children with metastatic solid tumors over the last four decadesCurrent state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.Inclusion of Adolescents and Young Adults in Cancer Clinical Trials.Declining childhood and adolescent cancer mortalityBone- and cartilage-forming tumors and ewing sarcoma: an update with a gnathic emphasis.Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma.Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group.Comparison of survival at adult versus pediatric treatment centers for rare pediatric tumors in an adolescent and young adult (AYA) population in the State of GeorgiaSystemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcomaOncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology GroupPrognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology GroupIL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastasesIfosfamide dose-intensification for patients with metastatic Ewing sarcomaPrimary Ewing's sarcoma of the sinonasal tract, eroding the ethmoid and sphenoid sinus with intracranial extension: A rare case reportNeoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysisImaging Features of Primary Tumors and Metastatic Patterns of the Extraskeletal Ewing Sarcoma Family of Tumors in Adults: A 17-Year Experience at a Single Institution.Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors
P2860
Q26752425-298BEA1D-FBA0-4E7E-B0A6-103DF6B65264Q26782649-88274D85-FCC4-437F-9575-D253E9B2F91DQ26797518-D74C698C-EA8A-4257-A2CE-8B77E6D37E8DQ26801785-C0270299-CC75-41BA-9A1D-7215DB713167Q26829949-AB88A77C-A732-42F6-A6A2-2C0BADAD337FQ27027664-7F0CD10A-8494-4CFA-9B8B-FF3F3B0AA7ADQ28073218-4A5E8A95-8529-4738-9824-5E8F77D6DCA4Q28085071-03904924-B9DF-4F85-893B-A0EFF105A5DDQ28541625-DEE27F4F-BBB4-472C-9C8B-368ACFE353A2Q30380209-5F966A44-8B12-40C6-9513-9C03B3260311Q33428775-02E8F9E3-27D8-48FE-92AE-7616A92983A0Q33436678-D46C6AEA-1352-43AF-9F80-93CBF4183F4AQ33693504-20A8ED3A-29CA-41A0-A8F2-2CDE81A01B42Q33697629-4D9AFDE7-6B40-4732-98BE-F7ABF0490B1CQ33758471-169D19B4-325D-4ABB-B9F7-52B62F6CBE9AQ33805175-57CAC8FB-AE79-4567-B161-74523150A801Q33835657-6D04492A-DE47-4946-B44D-7F704F723D55Q33859567-CFA0F71C-D809-4D4E-B987-F92487E4806BQ33863587-43D4E4CE-3E33-42B5-AC8F-9F32434D0472Q33872384-1F54A5A7-C97D-4493-8311-ED01BF742935Q33922505-E5BD6DA9-2A53-4642-8BB3-9AFEFEF0B4B3Q34060045-799F36F7-4D39-4F30-878F-50AD63AAE796Q34577384-4AD04260-B7CC-41A2-B3EB-ED9A05D50C76Q34589401-E2CD8F98-77CB-4080-9351-A45CAE504E03Q34762699-5788CF92-68E5-49FC-AEFF-FCB45B3619E6Q35007934-8170DB1B-1EC2-4961-A89C-C4EC2CADB19DQ35008064-3FA0F68E-29FF-470F-887E-F2BFBAD3ACECQ35118454-D8565ED4-DED7-4190-8FA9-E6D265699A48Q35149569-FB764FA5-AB5E-4964-8D5A-7EAB5C5F379AQ35212670-533B8C46-7A5E-45DA-9028-A585FBE4C40CQ35224434-0ECDAAF2-BAC5-45EA-B1D7-A1080DC8554BQ35607070-65A4BF32-B1F2-4CC9-8A81-CA368F9A3A4EQ35688154-EDE9257D-42DC-450A-944B-5FF1194C6DEAQ35717574-03DC9EA6-A20F-4DBB-A2F3-23D8BC3F4DCAQ35740170-D62A73FF-2099-460D-B815-50ED4542280AQ35760189-38420E99-BEEC-4C9F-8064-C70531D76334Q35803496-62C3679B-E0D4-428C-8B82-7D9991B8E580Q35826810-718372CB-4D47-452B-B49D-A6103516A78DQ35843655-06ECAA51-8388-46A9-A2BC-7A6CC5519CB9Q36038953-E61AB9B8-88EB-473F-9DD6-DAF5E627175A
P2860
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Randomized controlled trial of ...... the Children's Oncology Group.
@ast
Randomized controlled trial of ...... the Children's Oncology Group.
@en
type
label
Randomized controlled trial of ...... the Children's Oncology Group.
@ast
Randomized controlled trial of ...... the Children's Oncology Group.
@en
prefLabel
Randomized controlled trial of ...... the Children's Oncology Group.
@ast
Randomized controlled trial of ...... the Children's Oncology Group.
@en
P2093
P2860
P356
P1476
Randomized controlled trial of ...... the Children's Oncology Group.
@en
P2093
Aaron R Weiss
Bruce R Pawel
Daniel C West
Holcombe E Grier
John H Healey
John P Dormans
Karen Marcus
Mark D Krailo
Paul S Dickman
Richard B Womer
P2860
P304
P356
10.1200/JCO.2011.41.5703
P407
P577
2012-10-22T00:00:00Z